IL10 and metabolic dysfunction-associated steatotic liver disease: A recent study demonstrates that the gut microbiota in 32 NAFLD-HCC patients can reduce the expansion of CD8+ T cells but augment the expansion of IL-10+ Treg cells compared with 28 NAFLD-cirrhosis and 30 non-NAFLD controls [32].